The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

The Pan American Health Organization (PAHO) has issued an epidemiological alert regarding the increased risk of dengue ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.